|
WO2008091643A2
|
|
Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy
|
|
JP2007320969A
|
|
Method for reconstructing multiple epitope-containing antigen for causing immune response, and composition
|
|
US2007092522A1
|
|
Method and composition for reconforming multi-epitopic antigens to initiate an immune response
|
|
AU2006203074A1
|
|
Method for diagnosing efficacy of xenotypic antibody therapy
|
|
AU2003286463A1
|
|
Therapeutic adjuvant
|
|
CA2481796A1
|
|
Binding agents and their use in targeting tumor cells
|
|
AT500649A1
|
|
Combination therapy for disease treatment
|
|
AU2002335932B2
|
|
Therapeutic compositions that alter the immune response
|
|
US7147850B2
|
|
Therapeutic binding agents against MUC-1 antigen and methods for their use
|
|
EP1821104A2
|
|
Method for diagnosing efficacy of xenotypic antibody therapy
|
|
EP1254374A2
|
|
Method for diagnosing efficacy of xenotypic antibody therapy
|
|
US7318921B2
|
|
Therapeutic compositions that alter the immune response
|
